Pharmacogenetics in cardiovascular disorders: An update on the principal drugs

QR Code

Pharmacogenetics in cardiovascular disorders: An update on the principal drugs

In the coming years, genomics will impact clinical practice in multiple ways. However, one of the most important applications will be in the determination of the best treatments in personalized medicine. This is, in fact, one of the fields in which genetic variants have already been most successful...

Full description

Bibliographic Details
Main Authors:	Predazzi, I., Mango, R., Norata, Giuseppe, Di Daniele, N., Sergi, D., Romeo, F., Novelli, G.
Format:	Journal Article
Published:	2013
Online Access:	http://hdl.handle.net/20.500.11937/55833

Similar Items

Pipeline pharmacogenetics: A novel approach to integrating pharmacogenetics into drug development
by: Akkari, Patrick, et al.
Published: (2009)

Association between OLR1 K167N SNP and intima media thickness of the common carotid artery in the general population
by: Predazzi, I., et al.
Published: (2012)

Trained immunity and cardiovascular disease: Is it time for translation to humans?
by: Norata, Giuseppe
Published: (2018)

Pharmacogenetics, pharmacogenomics and airway disease
by: Hall, Ian P.
Published: (2002)

IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general population
by: Dhyani, A., et al.
Published: (2015)

Pharmacogenetics of beta adrenergic blockers: their clinical significance
by: Elsayed, Tarek Mohamed Ali
Published: (2009)

The missing link between high-density lipoprotein cholesterol and inflammatory response in cardiovascular disease
by: Ammirati, E., et al.
Published: (2014)

Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease
by: Ho, Chau Le Bao, et al.
Published: (2022)

Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
by: Bonacina, F., et al.
Published: (2013)

Long pentraxin PTX3 as a prognostic marker of cardiovascular mortality in patients with chronic kidney disease
by: Baragetti, A., et al.
Published: (2017)

Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia
by: Ware, James S., et al.
Published: (2017)

Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Bannur, Zakaria, et al.
Published: (2014)

LOX-1 inhibition in ApoE KO mice using a schizophyllan-based antisense oligonucleotide therapy
by: Amati, F., et al.
Published: (2012)

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Amin, Arwa M., et al.
Published: (2017)

Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
by: Ruscica, M., et al.
Published: (2017)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

Drug treatment and cost of cardiovascular disease in Australia
by: Ademi, Z., et al.
Published: (2009)

Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Zakaria, Bannur, et al.
Published: (2014)

The role of pharmacogenetic variation in metoprolol CYP2D6 genotypes polymorphism
by: Wan Sulaiman, Wan Mohd. Azizi, et al.
Published: (2011)

Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies
by: Loh, M., et al.
Published: (2013)

Nose to brain drug delivery: a recent update
by: Chatterjee, Bappaditya
Published: (2017)

Recent update on nanoemulgel as topical drug delivery system
by: Choudhury, Hira, et al.
Published: (2017)

New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs
by: Norata, Giuseppe, et al.
Published: (2013)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
by: Roberts, B., et al.
Published: (2023)

A Clinical And Pharmacogenetic Investigation Of Methadone Maintenance Therapy (MMT) In Opiate Dependent Individuals
by: Mohamad, Nasir
Published: (2011)

Genetic polymorphism of drug metabolizing enzymes and estrogen receptor in pharmacogenetics of tamoxifen: implication for optimization of breast cancer treatment / Teh Lay Kek and Mohd Zaki Salleh
by: Lay Kek, Teh, et al.
Published: (2010)

Update in respiratory sleep disorders: Epilogue to a modern review series
by: Malhotra, A., et al.
Published: (2018)

Update in respiratory sleep disorders: Prologue to a modern review series
by: Eastwood, Peter, et al.
Published: (2017)

A pharmacogenetics study on acute pain perception among patents on methadone maintenance therapy (MMT)
by: Zahari, Zalina
Published: (2016)

Co-occurring posttraumatic stress disorder and drug disorders
by: Marsh, Alison
Published: (2008)

Knowledge based system with embedded intelligent heart sound analyser for diagnosing cardiovascular disorders
by: A.F.M., Hani, et al.
Published: (2007)

Development of a polysaccharide-based hydrogel drug delivery system (DDS): An update
by: Pushpamalar, Janarthanan, et al.
Published: (2021)

The zebrafish embryo derivative affects cell viability of epidermal cells: A possible role in the treatment of psoriasis
by: Norata, Giuseppe, et al.
Published: (2013)

Knowledge, perception and confidence of physicians and pharmacists at IIUM Medical Centre towards pharmacogenetics application in clinical setting
by: Azmi, Diyana, et al.
Published: (2019)

Benchmarking in silico tools for the functional assessment of DNA variants using a set of strictly pharmacogenetic variants
by: Chua, Eng Wee, et al.
Published: (2019)

The Physiological/Pathophysiological Significance of Vitamin D in Cancer, Cardiovascular Disorders and Beyond
by: Almatar, Manaf, et al.
Published: (2017)

Cardiovascular risk factors of Alzheimer's disease and other neurocognitive disorders in Malaysia
by: Ibrahim, Buhari, et al.
Published: (2021)

Co-occurring drug and personality disorders
by: Marsh, Alison
Published: (2008)

Gastro-retentive drug delivery systems and their in vivo success: A recent update
by: Mandal, Uttam Kumar, et al.
Published: (2016)

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)